GGrantIndex
← Leaderboards

Don L Devoe

Univ Of Maryland, College Park

$9,742,801
Attributed
$12,344,564
Total exposure
10
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,344,564 · 10

By mechanism

R01$6,246,396 · 4
U19$4,221,164 · 1
R21$1,877,004 · 5

Top collaborators

Most similar at Univ Of Maryland, College Park

Same institution · by research overlap

Others in their field

Top investigators on “Technology

Research focus

TechnologySamplingMicrofluidicsInvestigationResolutionBaseCoupledDesignDevicesDetectionCostPerformanceLiquid SubstanceSourceEnvironmentOperationEvaluationClinical ResearchElementsDepositionPreventProteinsReagentCell Culture Techniques

Grant awards (28)

A rapid, automated system for bacteria profiling of intra-abdominal infections$548,325
R01 · FY2025 · AI · contact PI
Rapid Antibiotic Susceptibility Testing via Selective Lysis and Nanogap Trapping$490,093
R01 · FY2025 · AI · contact PI
Advanced Bioaerosols Technology Core$432,972
U19 · FY2025 · AI · contact PI
Advanced Bioaerosols Technology Core$1,627,452
U19 · FY2024 · AI · contact PI
A rapid, automated system for bacteria profiling of intra-abdominal infections$581,349
R01 · FY2024 · AI · contact PI
Microcyclone arrays for high resolution bioaerosol fractionation and viable virus collection$234,000
R21 · FY2024 · AI · contact PI
A rapid, automated system for bacteria profiling of intra-abdominal infections$581,349
R01 · FY2023 · AI · contact PI
Advanced Bioaerosols Technology Core$378,402
U19 · FY2023 · AI · contact PI
Microcyclone arrays for high resolution bioaerosol fractionation and viable virus collection$194,270
R21 · FY2023 · AI · contact PI
Advanced Bioaerosols Technology Core$700,284
U19 · FY2022 · AI · contact PI
A rapid, automated system for bacteria profiling of intra-abdominal infections$517,373
R01 · FY2022 · AI · contact PI
Enabling exosome biomarker development via digitized single vesicle analysis$428,266
R01 · FY2022 · GM
Elucidating Airborne SARS-CoV-2 Infectivity at Single Aerosol Resolution$414,425
R21 · FY2022 · AI · contact PI
Nanohydrocyclones for scalable extracellular vesicle purification and drug loading$191,401
R21 · FY2022 · HL · contact PI
Advanced Bioaerosols Technology Core$1,082,054
U19 · FY2021 · AI · contact PI
Enabling exosome biomarker development via digitized single vesicle analysis$428,266
R01 · FY2021 · GM
A rapid, automated system for bacteria profiling of intra-abdominal infections$426,147
R01 · FY2021 · AI · contact PI
Nanohydrocyclones for scalable extracellular vesicle purification and drug loading$230,093
R21 · FY2021 · HL · contact PI
Enabling exosome biomarker development via digitized single vesicle analysis$428,266
R01 · FY2020 · GM
Enabling exosome biomarker development via digitized single vesicle analysis$428,266
R01 · FY2019 · GM
Single Molecule Mass Spectrometry in a Microfluidic Nanopore Chip$213,940
R21 · FY2010 · EB · contact PI
Microfluidic Platform for Probing Ceramide Channels$185,625
R21 · FY2010 · EB · contact PI
Proteomics of Cell Death via 2-D Microfluidic Profiling$236,484
R01 · FY2009 · GM · contact PI
Microfluidic Platform for Probing Ceramide Channels$213,250
R21 · FY2009 · EB · contact PI
Proteomics of Cell Death via 2-D Microfluidic Profiling$284,085
R01 · FY2008 · GM · contact PI
Proteomics of Cell Death via 2-D Microfluidic Profiling$287,636
R01 · FY2007 · GM · contact PI
Proteomics of Cell Death via 2-D Micorfluidic Profiling$288,926
R01 · FY2006 · GM · contact PI
Proteomics of Cell Death via 2-D Microfluidic Profiling$291,565
R01 · FY2005 · GM